Binx Health said that when it received FDA CLIA waiver, it already had a strategic partner for sales of its POC platform and chlamydia and gonorrhea tests.
RADx-UP is funding multiple efforts to determine how marginalized groups, such as undocumented immigrants and those in rural areas, can access testing.
The Rehovot, Israel-based firm expects to soon receive marketing clearance from the US Food and Drug Administration for its methylation-based Bladder EpiCheck test.
CA Healthcare Acquisition, a special purpose acquisition company, said the transaction will support the development of LumiraDx’s pipeline of more than 30 assays.
Most commonly associated with test analysis, such tools are also seeing uptake by large reference labs for applications like specimen routing and billing support.
The company's test uses self-collected saliva samples from potential parents to assess their future child's genetic predisposition to various diseases.
The contracts are for two lateral flow rapid antigen tests, a laboratory-based test to detect and identify SARS-CoV-2 variants, and a rapid RT-PCR test.